Avail upto 30% off on all reports till July 31st.

Europe Diagnostic Specialty Antibodies Market 2020-2027 by Type (Monoclonal, Polyclonal, Others), Application (Oncology, Hepatitis, Infectious, Dengue), End User (Hospitals, Diagnostic Labs), and Country: Trend Outlook and Growth Opportunity

Date: Jun 30 2021
|
Grace Market Data
|
Number of Pages: 91
|
Category: Healthcare

Europe diagnostic specialty antibodies market accounted for $5,432.3 million in 2020 and will grow by 4.5% annually over 2020-2027 owing to the high number of patient pool undergoing diagnosis of HIV and growing demand for speciality diagnostics around the world, the advancements in DNA based technologies and diagnostics, and the increase in the prevalence of diseases such as infectious diseases, influenza and cancer.
Highlighted with 30 tables and 38 figures, this 91-page report “Europe Diagnostic Specialty Antibodies Market 2020-2027 by Type (Monoclonal, Polyclonal, Others), Application (Oncology, Hepatitis, Infectious, Dengue), End User (Hospitals, Diagnostic Labs), and Country: Trend Outlook and Growth Opportunity” is based on a comprehensive research of the entire Europe diagnostic specialty antibodies market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe diagnostic specialty antibodies market in every aspect of the classification from perspectives of Type, Application, End User, and Country.

Based on Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
• Monoclonal Antibodies
• Polyclonal Antibodies
• Other Types

Based on Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
• Natural/Biological Products
• Synthetic Products

Based on Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
• Oncology Diagnosis
• Hepatitis Diagnosis
• Infectious Disease Diagnosis
• Dengue Diagnostics
• Tuberculosis Diagnostics
• HIV Diagnostics
• Other Applications

Based on End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
• Hospitals & Clinics
• Diagnostic Laboratories
• Other End Users

Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2017-2027. The breakdown of key national markets by Type, Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
Abcam plc
Agilent Technologies, Inc.
Aytu BioScience, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Boehringer Ingelheim International GmbH
Creative Diagnostics
Enzo Life Sciences, Inc.
F. Hoffmann-La Roche AG
Merck KGaA
Polymun Scientific Immunbiologische Forschung GmbH
Sanofi S.A.
Sartorius AG
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 5
   1.1 Industry Definition and Research Scope 5
          1.1.1 Industry Definition 5
          1.1.2 Research Scope 6
   1.2 Research Methodology 9
          1.2.1 Overview of Market Research Methodology 9
          1.2.2 Market Assumption 10
          1.2.3 Secondary Data 10
          1.2.4 Primary Data 10
          1.2.5 Data Filtration and Model Design 11
          1.2.6 Market Size/Share Estimation 12
          1.2.7 Research Limitations 13
   1.3 Executive Summary 14
2 Market Overview and Dynamics 16
   2.1 Market Size and Forecast 16
          2.1.1 Impact of COVID-19 on World Economy 17
          2.1.2 Impact of COVID-19 on the Market 19
   2.2 Major Growth Drivers 21
   2.3 Market Restraints and Challenges 24
   2.4 Emerging Opportunities and Market Trends 27
   2.5 Porter’s Fiver Forces Analysis 31
3 Segmentation of Europe Market by Type 35
   3.1 Market Overview by Type 35
   3.2 Monoclonal Antibodies 37
   3.3 Polyclonal Antibodies 38
   3.4 Other Types 39
4 Segmentation of Europe Market by Application 40
   4.1 Market Overview by Application 40
   4.2 Oncology Diagnosis 42
   4.3 Hepatitis Diagnosis 43
   4.4 Infectious Disease Diagnosis 44
   4.5 Dengue Diagnostics 45
   4.6 Tuberculosis Diagnostics 46
   4.7 HIV Diagnostics 47
   4.8 Other Applications 48
5 Segmentation of Europe Market by End User 49
   5.1 Market Overview by End User 49
   5.2 Hospitals & Clinics 51
   5.3 Diagnostic Laboratories 52
   5.4 Other End Users 53
6 European Market 2020-2027 by Country 54
   6.1 Overview of European Market 54
   6.2 UK 57
   6.3 France 59
   6.4 Germany 61
   6.5 Spain 63
   6.6 Italy 65
   6.7 Russia 67
   6.8 Rest of European Market 69
7 Competitive Landscape 71
   7.1 Overview of Key Vendors 71
   7.2 New Product Launch, Partnership, Investment, and M&A 74
   7.3 Company Profiles 75

Abbott Laboratories 75
Abcam plc 77
Agilent Technologies, Inc. 78
Aytu BioScience, Inc. 79
Becton, Dickinson and Company 80
Bio-Rad Laboratories, Inc. 81
Boehringer Ingelheim International GmbH 82
Creative Diagnostics 83
Enzo Life Sciences, Inc. 84
   F. Hoffmann-La Roche AG 85

Merck KGaA 86
Polymun Scientific Immunbiologische Forschung GmbH 87
Sanofi S.A. 88
Sartorius AG 89
Thermo Fisher Scientific Inc. 90
RELATED REPORTS 91

Table 1. Snapshot of Europe Diagnostic Specialty Antibodies Market in Balanced Perspective, 2020-2027 15
Table 2. Growth Rate of World GDP, 2020-2022 18
Table 3. Main Product Trends and Market Opportunities in Europe Diagnostic Specialty Antibodies Market 27
Table 4. Europe Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn 35
Table 5. Europe Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn 40
Table 6. Europe Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn 49
Table 7. Europe Diagnostic Specialty Antibodies Market by Country, 2017-2027, $ mn 56
Table 8. UK Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn 58
Table 9. UK Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn 58
Table 10. UK Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn 58
Table 11. France Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn 60
Table 12. France Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn 60
Table 13. France Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn 60
Table 14. Germany Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn 62
Table 15. Germany Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn 62
Table 16. Germany Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn 62
Table 17. Spain Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn 64
Table 18. Spain Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn 64
Table 19. Spain Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn 64
Table 20. Italy Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn 66
Table 21. Italy Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn 66
Table 22. Italy Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn 66
Table 23. Russia Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn 68
Table 24. Russia Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn 68
Table 25. Russia Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn 68
Table 26. Diagnostic Specialty Antibodies Market in Rest of Europe by Country, 2017-2027, $ mn 70
Table 27. Abbott Laboratories: Company Snapshot 75
Table 28. Abbott Laboratories: Business Segmentation 75
Table 29. Abbott Laboratories: Product Portfolio 76
Table 30. Abbott Laboratories: Revenue, 2017-2019, $ mn 76

Figure 1. Research Method Flow Chart 9
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 12
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027 14
Figure 4. Europe Diagnostic Specialty Antibodies Market, 2017-2027, $ mn 16
Figure 5. Impact of COVID-19 on Business 19
Figure 6. Primary Drivers and Impact Factors of Europe Diagnostic Specialty Antibodies Market 21
Figure 7. Primary Restraints and Impact Factors of Europe Diagnostic Specialty Antibodies Market 24
Figure 8. Investment Opportunity Analysis 28
Figure 9. Porter’s Fiver Forces Analysis of Europe Diagnostic Specialty Antibodies Market 31
Figure 10. Breakdown of Europe Diagnostic Specialty Antibodies Market by Type, 2020-2027, % of Revenue 35
Figure 11. Contribution to Europe 2021-2027 Cumulative Revenue by Type, Value ($ mn) and Share (%) 36
Figure 12. Europe Diagnostic Specialty Antibodies Market: Monoclonal Antibodies, 2017-2027, $ mn 37
Figure 13. Europe Diagnostic Specialty Antibodies Market: Polyclonal Antibodies, 2017-2027, $ mn 38
Figure 14. Europe Diagnostic Specialty Antibodies Market: Other Types, 2017-2027, $ mn 39
Figure 15. Breakdown of Europe Diagnostic Specialty Antibodies Market by Application, 2020-2027, % of Revenue 40
Figure 16. Contribution to Europe 2021-2027 Cumulative Revenue by Application, Value ($ mn) and Share (%) 41
Figure 17. Europe Diagnostic Specialty Antibodies Market: Oncology Diagnosis, 2017-2027, $ mn 42
Figure 18. Europe Diagnostic Specialty Antibodies Market: Hepatitis Diagnosis, 2017-2027, $ mn 43
Figure 19. Europe Diagnostic Specialty Antibodies Market: Infectious Disease Diagnosis, 2017-2027, $ mn 44
Figure 20. Europe Diagnostic Specialty Antibodies Market: Dengue Diagnostics, 2017-2027, $ mn 45
Figure 21. Europe Diagnostic Specialty Antibodies Market: Tuberculosis Diagnostics, 2017-2027, $ mn 46
Figure 22. Europe Diagnostic Specialty Antibodies Market: HIV Diagnostics, 2017-2027, $ mn 47
Figure 23. Europe Diagnostic Specialty Antibodies Market: Other Applications, 2017-2027, $ mn 48
Figure 24. Breakdown of Europe Diagnostic Specialty Antibodies Market by End User, 2020-2027, % of Revenue 49
Figure 25. Contribution to Europe 2021-2027 Cumulative Revenue by End User, Value ($ mn) and Share (%) 50
Figure 26. Europe Diagnostic Specialty Antibodies Market: Hospitals & Clinics, 2017-2027, $ mn 51
Figure 27. Europe Diagnostic Specialty Antibodies Market: Diagnostic Laboratories, 2017-2027, $ mn 52
Figure 28. Europe Diagnostic Specialty Antibodies Market: Other End Users, 2017-2027, $ mn 53
Figure 29. Breakdown of European Diagnostic Specialty Antibodies Market by Country, 2020 and 2027, % of Revenue 55
Figure 30. Contribution to Europe 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%) 56
Figure 31. Diagnostic Specialty Antibodies Market in UK, 2017-2027, $ mn 57
Figure 32. Diagnostic Specialty Antibodies Market in France, 2017-2027, $ mn 59
Figure 33. Diagnostic Specialty Antibodies Market in Germany, 2017-2027, $ mn 61
Figure 34. Diagnostic Specialty Antibodies Market in Spain, 2017-2027, $ mn 63
Figure 35. Diagnostic Specialty Antibodies Market in Italy, 2017-2027, $ mn 65
Figure 36. Diagnostic Specialty Antibodies Market in Russia, 2017-2027, $ mn 67
Figure 37. Diagnostic Specialty Antibodies Market in Rest of Europe, 2017-2027, $ mn 69
Figure 38. Growth Stage of Europe Diagnostic Specialty Antibodies Industry over the Forecast Period 71

Electronic files(PDF) of market research reports will be dispatched within 48-72 hours. (Mon-Fri IST)

Select License Type

Why Choose InForGrowth?
  • Customer Insights
  • Market Opportunity Mapping
  • Competitive Intelligence for Key Companies
  • Market Entry Strategy
  • Product Mix and Pricing
  • Segmentation Analysis
  • Benchmarking Research based on Ecosystem and Interconnectivity
  • Market Attractiveness Framework
  • Demand-Supply Scenario & Performance Optimization
  • Technology Landscape & Revenue Augmenting Plans
  • Impact of Circular Economy or Digital Transformation Trends
  • Region Specific Reports / Country Specific Reports for Specific Topics
  • As Per Customer Need Section Wise Reports
  • Subscription Service with Real-Time Updates
  • Access to all the Research Studies in the Chosen Domains/Verticals
  • Pre and Post-Sales Service and Support
Need Help?
+
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.